BoB@JPM: Academia To Industry With Oncolytics' Matt Coffey, Ph.D. - podcast episode cover

BoB@JPM: Academia To Industry With Oncolytics' Matt Coffey, Ph.D.

Feb 13, 202337 minTranscript available on Metacast
--:--
--:--
Listen in podcast apps:

Episode description

We love to hear from our listeners. Send us a message.

SPECIAL EDITION: BoB@JPM
The JP Morgan Healthcare Conference is a target-rich environment for conversations with the leaders of up-and-coming biopharma companies, so we took the Business of Biotech on the road. On today's episode, we sat down with Matt Coffey, Ph.D., who earned his Ph.D. in 1998 and turned his doctoral thesis into a biopharma company called Oncolytics in 1999. Dr. Coffey shares on his abrupt transition from academia to industry,  tells tales of the company's backstory, and updates us on its aggressive clinical activity spanning 7 wide-ranging oncology programs.

Access this and hundreds of episodes of the Business of Biotech videocast under the Listen & Watch tab at bioprocessonline.com.

Subscribe to our monthly Business of Biotech newsletter.

Get in touch with guest and topic suggestions: matt.pillar@lifescienceconnect.com

Find Matt Pillar on LinkedIn: https://www.linkedin.com/in/matthewpillar/